Year Book of Dermatology 2019
Jaypee Brothers Medical Publishers (Verlag)
978-93-89188-49-3 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
This yearbook on acne has collection of original abstract of path breaking research published in high impact factor journals that were published in the previous year. It presents breakthrough developments articles which were reviewed thoroughly and commented on the value of the article.
This book brings to you a collection of meticulously chosen articles focusing on the recent advances in the management of acne.
Articles selected from various peer-reviewed journals that were published in the last 12 month period.
In-depth evidence based discussion on clinical management of acne with a variety of treatment options such as hormonal, pharmacological and nonpharmacological therapy provides useful insights.
Each article has been reviewed by subject reviewers who have written comments on value of the article, previous knowledge on the subject, what the article add to the prevailing knowledge and practices, strong points and weaknesses of the article and other similar observations that have come in the last 12-month period.
Each article is accompanied by key messages, summarizing the article as well as highlighting the clinical experience of the reviewers.
A must read book for dermatologists, physicians and postgraduate students.
Shashi Kumar BM MD (DVL) FIADVL (Dermatopath) Associate Professor, Department of Dermatology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India Savitha AS MD (DVL) DNB FRGUHS (Dermatosurgery) Associate Professor, Department of Dermatology, Sapthagiri Institute of Medical Science and Research Centre, Bengaluru, Karnataka, India R Raghunatha Reddy MD (DVL) DNB FRGUHS (Dermatosurgery) Professor and Head, Department of Dermatology, Akash Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India
1. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel
2. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients aged 9 Years and Older
3. Once-daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate-to-severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-blind Clinical Trials
4. The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris
5. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-class Antibiotics for Women with Acne: A Retrospective Cohort Study 2010–2016
6. Clinical Experience with Once-daily Dapsone Gel, 7.5% Monotherapy in Patients with Acne Vulgaris
7. An Acne Survey from the World's Largest Annual Gathering of Twins
8. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel plus Oral Doxycycline in Subjects with Severe Inflammatory Acne who are Candidates for Oral Isotretinoin
9. Efficacy, Safety and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype
10. Clinical Significance of Neutrophil Gelatinase-associated Lipocalin and Galectin-7 in Tape-stripped Stratum Corneum of Acne Vulgaris
11. Risk of Depression among Patients with Acne: A Population-based Cohort Study using The Health Improvement Network (THIN) Database
12. Acne Development in Male Androgenetic Alopecia
13. Effects of Isotretinoin Treatment on Affective and Cognitive Functions in Adolescent Acne Vulgaris Patients
14. Analysis of Gut Microbiome in Patients with Acne Vulgaris
15. Isotretinoin Therapy: A Retrospective Cohort Analysis of Completion Rates and Factors Associated with Nonadherence
16. Photodynamic Therapy for Acne Conglobata of the Buttocks: Effective Anti-inflammatory Treatment with Good Cosmetic Outcome
17. Acneiform Eruptions: An Unusual Dermatological Side Effect of Ribavirin
18. Topical Dapsone Gel is a New Treatment Option for Acne Agminata
19. The Effect of Continuous High versus Low Dose Oral Isotretinoin Regimens on Dermcidin Expression in Patients with Moderate-to-severe Acne Vulgaris
20. Transgender Adolescents and Acne: A Case Series
21. Chemical Peels in the Treatment of Acne: Patient Selection and Perspectives
22. A Novel Cognitive Stress Management Technique for Acne Vulgaris: A Short Report of a Pilot Experimental Study
23. Evaluation of the Efficacy of Microneedle Fractional Radiofrequency in Turkish Patients with Atrophic Facial Acne Scars
24. Effect of Oral Isotretinoin on the Nucleocytoplasmic Distribution of FoxO1 and FoxO3 Proteins in Sebaceous Glands of Patients with Acne Vulgaris
25. Adult-onset Acne: Prevalence, Impact and Management Challenges
26. Acne: A Side Effect of Masculinizing Hormonal Therapy in Transgender Patients
27. Efficacy and Safety Profile of Spironolactone 50 mg v/s Isotretinoin 10 mg in the Treatment of Female Patients with Acne Vulgaris Grade 1-2—A Double Blinded, Randomized Comparative Study
28. The Microbiome in Preadolescent Acne: Assessment and Prospective Analysis of the Influence of Benzoyl Peroxide
29. Association of Systemic Antibiotic Treatment of Acne with Skin Microbiota Characteristics
30. Novel Nicotinamide Skin-adhesive Hot Melt Extrudates for Treatment of Acne
31. Treatment of Acne with a Combination of Propolis, Tea Tree Oil and Aloe vera Compared to Erythromycin Cream: Two Double-blind Investigations
32. The Safety and Efficacy of Four Different Fixed Combination Regimens of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel for the Treatment of Acne Vulgaris: Results from a Randomized Controlled Study
33. Survey of Acne-related Post-inflammatory Hyperpigmentation in the Middle East
34. The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-year Retrospective Study
35. Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars
36. Evaluation the Efficacy of Trichloroacetic Acid 33% in Treatment of Oral Retinoid-induced Cheilitis Compared with Placebo (Vaseline): A Randomized Pilot Study
37. Light Therapies for Acne: Abridged Cochrane Systematic Review including GRADE Assessments
38. Dapsone-loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization and In Vivo Skin Deposition Assay
39. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-month Randomized, Vehicle-controlled Trial using Intra-individual Comparison
40. Complementary and Alternative Methods for Treatment of Acne Vulgaris: A Systematic Review
41. Effects of the Myrtle Essential Oil on the Acne Skin—Clinical Trials for Korean Women
42. Comparison of Efficacy of Commercially Available versus Freshly Prepared Salicylic Acid Peel in Treatment of Acne: A Randomized Open-label Study
43. A Comparison of Combined Oral Contraceptives Containing Chlormadinone Acetate versus Drospirenone for the Treatment of Acne and Dysmenorrhea: A Randomized Trial
44. Efficacy and Adverse Events of Oral Isotretinoin for Acne: A Systematic Review
45. Aromatherapy, Botanicals, and Essential Oils in Acne
46. A Review of Diagnosis and Treatment of Acne in Adult Female Patients
47. Clinical Evidence for Washing and Cleansers in Acne Vulgaris: A Systematic Review
48. ROS-responsive Microneedle Patch for Acne Vulgaris Treatment
49. Optimizing the Use of Topical Retinoids in Asian Acne Patients
50. Comparative Study of the Efficacy of Platelet-rich Plasma Combined with Carboxytherapy versus its Use with Fractional Carbon Dioxide Laser in Atrophic Acne Scars
51. Effects of Oral Supplementation with FOS and GOS Prebiotics in Women with Adult Acne: The “SO Sweet” Study: A Proof-of-concept Pilot Trial
52. Approaches to Limit Systemic Antibiotic Use in Acne: Systemic Alternatives, Emerging Topical Therapies, Dietary Modification, and Laser and Light-based Treatments
53. The Efficacy and Tolerability of 5-aminolevulinic Acid 5% Thermosetting Gel Photodynamic Therapy in the Treatment of Mild-to-moderate Acne Vulgaris. A Two-center, Prospective Assessor-blinded, Proof-of-concept Study
54. Combination Chemical Peels are More Effective than Single Chemical Peel in Treatment of Mild-to-moderate Acne Vulgaris: A Split Face Comparative Clinical Trial
55. Comparison of Efficacy of Aminolevulinic Acid Photodynamic Therapy versus Adapalene Gel plus Oral Doxycycline for Treatment of Moderate Acne Vulgaris – A Simple, Blind, Randomized, and Controlled Trial
56. Microneedling by Dermapen and Glycolic Acid Peel for the Treatment of Acne Scars: Comparative Study
57. Antipruritic Efficacies of Doxycycline and Erythromycin in the Treatment of Acne Vulgaris: A Randomized Single-blinded Pilot Study
58. Does Isotretinoin Cause Depression and Anxiety in Acne Patients?
59. Treatment of Atrophic Acne Scarring with Fractional Micro-plasma Radiofrequency in Chinese Patients: A Prospective Study
60. Comparison of Novel Dual Mode versus Conventional Single Pass of a 1450-nm Diode Laser in the Treatment of Acne Vulgaris for Korean Patients: A 20-week Prospective, Randomized, Split-face Study
61. Resurfacing of Facial Acne Scars with a New Variable-pulsed Er:YAG Laser in Fitzpatrick Skin Types IV and V
62. A Novel Topical Minocycline Foam for the Treatment of Moderate-to-severe Acne Vulgaris: Results of 2 Randomized, Double-blind, Phase 3 Studies
63. Management of Comedonal Acne Vulgaris with Fixed-combination Topical Therapy
64. Blunt Cannula Subcision is more Effective than Nokor Needle Subcision for Acne Scars Treatment
65. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-severe Acne Vulgaris in a Preadolescent Population
66. Efficacy of Two Plant Extracts Against Acne Vulgaris: Initial Results of Microbiological Tests and Cell Culture Studies
67. Female Type of Adult Acne: Physiological and Psychological Considerations and Management
68. The Efficacy and Safety of Nonpharmacological Therapies for the Treatment of Acne Vulgaris: A Systematic Review and Best-evidence Synthesis
69. Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3% Fixed-dose Combination Gel versus Topical Combination Therapy of Adapalene 0.1% Gel and Clindamycin Phosphate 1.2% Gel in the Treatment of Acne Vulgaris in Japanese Patients: A Multicenter, Randomized, Investigator-blind, Parallel-group Study
70. Screening of Body Dysmorphic Disorder in Acne Patients: A Pilot Study
71. A Qualitative Investigation of the Impact of Acne on Health-related Quality of Life: Development of a Conceptual Model
72. Host-microbiome Interactions and Recent Progress into Understanding the Biology of Acne Vulgaris
73. Acne in Lom©, Togo: Clinical Aspects and Quality of Life of Patients
74. The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence with Acne Medications
75. Exploring the Relationship between Stress and Acne: A Medical Student’s Perspective
76. The Impact of Acne and Facial Postinflammatory Hyperpigmentation on Quality of Life and Self-esteem of Newly Admitted Nigerian Undergraduates
77. Which Acne Treatment has the Best Influence on Health-related Quality of Life? Literature Review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
78. Stressful Life Events and Psychiatric Comorbidity in Acne–A Case Control Study
79. The Evaluation of Psychiatric Comorbidity, Self-injurious Behavior, Suicide Probability, and other Associated Psychiatric Factors (Loneliness, Self-esteem, Life Satisfaction) in Adolescents with Acne: A Clinical Pilot Study
80. Acne Relapses: Impact on Quality of Life and Productivity
81. The Mental Health Burden in Acne Vulgaris and Rosacea: An Analysis of the US National Inpatient Sample
82. The Therapeutic Effect of Tanshinone IIA on Propionibacterium acnes-induced Inflammation In Vitro
83. Anti-acne Properties of Hydrophobic Fraction of Red Ginseng (Panax Ginseng C.A. Meyer) and its Active Components
84. Mechanistic Insight into the Activity of a Sulfone Compound Dapsone on Propionibacterium (Newly Reclassified as Cutibacterium) Acne's–mediated Cytokine Production
85. Lipidomics Reveals Skin Surface Lipid Abnormity in Male Youth Acne
86. Acne Vulgaris Severity Graded by In Vivo Reflectance Confocal Microscopy and Optical Coherence Tomography
87. Vitamin D Levels in Acne Vulgaris Patients Treated with Oral Isotretinoin
88. The Effect of Milk Consumption on Acne: A Meta-analysis of Observational Studies
89. Acne and Nutrition: Hypotheses, Myths and Facts
90. Enhancement of Lipid Content and Inflammatory Cytokine Secretion in SZ95 Sebocytes by Palmitic Acid Suggests a Potential Link between Free Fatty Acids and Acne Aggravation
91. Characterization of Cutibacterium acnes Phylotypes in Acne and In Vivo Exploratory Evaluation of Myrtacine
92. Atrophic Scar Formation in Acne Patients involves Long-acting Immune Responses with Plasma Cells and Alteration of Sebaceous Gland
93. Lesional and Circulating Levels of Interleukin 17 and 25 Hydroxy-cholecalciferol in Active Acne Vulgaris: Correlation to Disease Severity
94. Clinical Efficacy of 0.5% Topical Mangosteen Extract in Nanoparticle Loaded Gel in Treatment of Mild?to?moderate Acne Vulgaris: A 12-Week, Split-Face, Double-blinded, Randomized, Controlled Trial
95. The Influence of Exposome on Acne
96. Association of Interleukin-6 Gene Promoter Polymorphism with Acne Vulgaris and its Severity
97. Genome-wide Meta-analysis Implicates Mediators of Hair Follicle Development and Morphogenesis in Risk for Severe Acne
98. Microbiological Profile of Sarecycline: A Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
99. Daily Intake of Soft Drinks and Moderate-to-severe Acne Vulgaris in Chinese Adolescents
100. New Concepts, Concerns, and Creations in Acne
101. The Anti-inflammatory Activities of Propionibacterium acnes CAMP Factor-targeted Acne Vaccines
102. Skin Ecology during Sebaceous Drought—How Skin Microbes Respond to Isotretinoin
103. Propionibacterium acnes-derived Extracellular Vesicles Promote Acne-like Phenotypes in Human Epidermis
104. Patients with Acne Vulgaris have a Distinct Gut Microbiota in Comparison with Healthy Controls
105. Inhibitory Effects of Euphorbia supina on Propionibacterium acnes-induced Skin Inflammation In Vitro and In Vivo
106. Isolation and Identification of the Follicular Microbiome: Implications for Acne Research
107. Expression of Inflammatory and Fibrogenetic Markers in Acne Hypertrophic Scar Formation: Focusing on Role of TGF- and IGF-1R
108. Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back
109. Short Lipopeptides Specifically Inhibit the Growth of Propionibacterium acnes with Antibacterial and Anti-inflammatory Dual Action
110. Plasma Exeresis for Active Acne Vulgaris: Clinical and In Vivo Microscopic Documentation of Treatment Efficacy by Means of Reflectance Confocal Microscopy
111. Licochalcone A Attenuates Acne Symptoms Mediated by Suppression of NLRP3 Inflammasome
112. Gut Microbiota Alterations in Moderate-to-severe Acne Vulgaris Patients
113. Overall and Subgroup Prevalence of Acne Vulgaris among Patients with Hidradenitis Suppurativa
114. Association of the TNF- Gene Promoter Polymorphisms at Nucleotide-238 and -308 with Acne Susceptibility: A Meta-analysis
115. Tumor Necrosis Factor a-308 G/A and Interleukin 1 b-511 C/T Gene Polymorphisms in Patients with Scarring Acne
116. SIG1459: A Novel Phytyl-Cysteine Derived TLR2 Modulator with In Vitro and Clinical Anti-acne Activity
117. Associations among Two Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and TaqI) in Acne Vulgaris: A Pilot Susceptibility Study
118. Using Network Oriented Research Assistant (NORA) Technology to Compare Digital Photographic with In-Person Assessment of Acne Vulgaris
119. Genetic Association between the NLRP3 Gene and Acne Vulgaris in a Chinese Population
120. Serum Irisin: A Prognostic Marker for Severe Acne Vulgaris
121. Primary Sebocytes and Sebaceous Gland Cell Lines for Studying Sebaceous Lipogenesis and Sebaceous Gland Diseases
122. Acne Vulgaris in Patients with Hidradenitis Suppurativa
123. Validation of 3D Skin Imaging for Objective Repeatable Quantification of Severity of Atrophic Acne Scarring
124. No Evidence for Follicular Keratinocyte Hyperproliferation in Acne Lesions as Compared to Autologous Healthy Hair Follicles
125. Seasonal Changes in Epidermal Ceramides are Linked to Impaired Barrier Function in Acne Patients
126. Cutibacterium acnes (Propionibacterium acnes) and Acne Vulgaris: A Brief Look at the Latest Updates
127. The In Vitro Antimicrobial Evaluation of Commercial Essential Oils and their Combinations against Acne
128. Seasonal Aggravation of Acne in Summers and the Effect of Temperature and Humidity in a Study in a Tropical Setting
129. Acne Prevalence in 9–14-year old Patients Attending Pediatric Ambulatory Clinics in Italy
130. Confocal Microscopy in Adult Women with Acne
131. Erythema-directed Digital Photography for the Enhanced Evaluation of Topical Treatments for Acne Vulgaris
132. Acne Vulgaris: The Metabolic Syndrome of the Pilosebaceous Follicle
133. Circular RNA Expression Profile Analysis of Severe Acne by RNA-Seq and Bioinformatics
134. Taxonomy and Phylogeny of Cutibacterium (formerly Propionibacterium) Acnes in Inflammatory Skin Diseases
135. Transforming Acne Care by Pediatricians: An Interventional Cohort Study
| Erscheinungsdatum | 10.05.2021 |
|---|---|
| Verlagsort | New Delhi |
| Sprache | englisch |
| Maße | 171 x 241 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| ISBN-10 | 93-89188-49-0 / 9389188490 |
| ISBN-13 | 978-93-89188-49-3 / 9789389188493 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
